Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 3/20 | 0.44 |
| ▸ | KDR | P35968 | 3/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 9/20 | 0.41 |
| ▸ | SUV39H2 | Q9H5I1 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | TTK | P33981 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21177871 | 0.90 | SYK (0.47) | SRCKDRPDE10APRKDCIRAK4 | |
| SCHEMBL30823276 | 0.90 | SYK (0.47) | SRCKDRPDE10APRKDCIRAK4 | |
| SCHEMBL21187399 | 0.90 | SYK (0.47) | SRCKDRPDE10APRKDCIRAK4 | |
| SCHEMBL30823290 | 0.81 | PIK3CD (0.40) | SRCKDRPRKDC | |
| SCHEMBL28461575 | 0.81 | PIK3CD (0.40) | SRCKDRPRKDC | |
| SCHEMBL22651983 | 0.81 | PIK3CD (0.40) | SRCKDRPRKDC | |
| SCHEMBL21187398 | 0.80 | RAF1 (0.40) | PRKDCSUV39H2 | |
| SCHEMBL21178579 | 0.80 | RAF1 (0.40) | PRKDCSUV39H2 | |
| SCHEMBL21178651 | 0.80 | PIK3CD (0.37) | SRCKDRPDE10APRKDCIRAK4 | |
| SCHEMBL30823294 | 0.80 | PIK3CD (0.37) | SRCKDRPDE10APRKDCIRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019143678-A1 | DNA-PK INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-07-25 | — | — | WO | disclosed |